Kandeel, Mahmoud <br/><br/>
Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.  [electronic resource] 

 -  Life sciences  Jun 2020 
 - 117627 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0631 
<br/><br/><label>Standard No.: </label>10.1016/j.lfs.2020.117627  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Antiviral Agents--chemistry<br/>Betacoronavirus--enzymology<br/>Binding Sites<br/>Coronavirus 3C Proteases<br/>Curcumin--chemistry<br/>Cysteine Endopeptidases--chemistry<br/>Drug Approval<br/>Drug Evaluation, Preclinical<br/>Drug Repositioning<br/>Hydrogen Bonding<br/>Hydrophobic and Hydrophilic Interactions<br/>Middle East Respiratory Syndrome Coronavirus--enzymology<br/>Models, Molecular<br/>Molecular Docking Simulation<br/>Protease Inhibitors--chemistry<br/>Severe acute respiratory syndrome-related coronavirus--enzymology<br/>SARS-CoV-2<br/>Sequence Alignment<br/>United States<br/>United States Food and Drug Administration<br/>Viral Nonstructural Proteins--chemistry